Brief: Champions Oncology says Q2 revenue rose 50 pct to $4.5 mln

Champions Oncology

29/11/2016 21:15

Nov 29 (Reuters) - Champions Biotechnology Inc  CSBR.O  
    * Champions Oncology reports 50% revenue growth, accelerated 
progress on path to profitability and future role changes of the 
senior leadership 
    * Q2 revenue rose 50 percent to $4.5 million 
    * Sees FY 2017 revenue $16 million to $18 million 
 
Source text for Eikon:  ID:nPntctc2a  
Further company coverage:  CSBR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))